TGFB1 and neuroblastoma: However in neuroblastoma, in pre-clinical studies, co-targeting of retinoid and TGFβ signaling pathways through combination of retionoic acid and Kartogenin (TGFβ signaling activating molecule) has decreased the viability of MYCN amplified neuroblastoma cells.